RBC Bioscience Past Earnings Performance
Past criteria checks 4/6
RBC Bioscience's earnings have been declining at an average annual rate of -38.5%, while the Life Sciences industry saw earnings growing at 22.4% annually. Revenues have been declining at an average rate of 11.7% per year. RBC Bioscience's return on equity is 2.7%, and it has net margins of 3.7%.
Key information
-38.5%
Earnings growth rate
-39.8%
EPS growth rate
Life Sciences Industry Growth | 5.5% |
Revenue growth rate | -11.7% |
Return on equity | 2.7% |
Net Margin | 3.7% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How RBC Bioscience makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 172 | 6 | 48 | 11 |
30 Sep 23 | 166 | 2 | 47 | 12 |
30 Jun 23 | 161 | -2 | 47 | 14 |
31 Mar 23 | 167 | 1 | 48 | 15 |
31 Dec 22 | 174 | 4 | 50 | 16 |
30 Sep 22 | 192 | 9 | 51 | 15 |
30 Jun 22 | 210 | 13 | 52 | 14 |
31 Mar 22 | 230 | 21 | 52 | 15 |
31 Dec 21 | 251 | 29 | 52 | 16 |
30 Sep 21 | 374 | 74 | 66 | 22 |
30 Jun 21 | 497 | 120 | 81 | 27 |
31 Mar 21 | 536 | 131 | 86 | 25 |
31 Dec 20 | 575 | 142 | 90 | 22 |
31 Dec 19 | 162 | 14 | 39 | 9 |
31 Dec 18 | 126 | 14 | 35 | 8 |
Quality Earnings: 6848 has high quality earnings.
Growing Profit Margin: 6848's current net profit margins (3.7%) are higher than last year (2.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6848's earnings have declined by 38.5% per year over the past 5 years.
Accelerating Growth: 6848's earnings growth over the past year (70.2%) exceeds its 5-year average (-38.5% per year).
Earnings vs Industry: 6848 earnings growth over the past year (70.2%) exceeded the Life Sciences industry 0.7%.
Return on Equity
High ROE: 6848's Return on Equity (2.7%) is considered low.